ANORO™ ELLIPTA™ approved as first once-daily dual bronchodilator for the treatment of COPD in the US
12y agoen
From the article
GlaxoSmithKline plc and Theravance, Inc. today announced that the US Food and Drug Administration (FDA) has approved ANORO ELLIPTA.
Continue reading on GSKYou might also wanna read
STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT·30m ago
UAB receives $4 million from Novo Nordisk to expand Live HealthSmart Alabama health initiative
The University of Alabama at Birmingham (UAB) received a $4 million investment from pharmaceutical company Novo Nordisk to expand its Live H
alreporter.com·47m agoKeenova eyes Xiaflex as first drug for plantar fibromatosis
pharmaphorum·1h ago
GSK ends dementia alliance with Alector after setbacks
pharmaphorum·3h ago
NICE aims to cut funding for Amgen lung cancer drug Lumykras
pharmaphorum·4h ago
Is pure play pharma's new pharmakon?
pharmaphorum·4h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.